<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33414559</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5438</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of human genetics : EJHG</Title><ISOAbbreviation>Eur J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Genetic analysis of ALS cases in the isolated island population of Malta.</ArticleTitle><Pagination><StartPage>604</StartPage><EndPage>614</EndPage><MedlinePgn>604-614</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41431-020-00767-9</ELocationID><Abstract><AbstractText>Genetic isolates are compelling tools for mapping genes of inherited disorders. The archipelago of Malta, a sovereign microstate in the south of Europe is home to a geographically and culturally isolated population. Here, we investigate the epidemiology and genetic profile of Maltese patients with amyotrophic lateral sclerosis (ALS), identified throughout a 2-year window. Cases were largely male (66.7%) with a predominant spinal onset of symptoms (70.8%). Disease onset occurred around mid-age (median age: 64 years, men; 59.5 years, female); 12.5% had familial ALS (fALS). Annual incidence rate was 2.48 (95% CI 1.59-3.68) per 100,000 person-years. Male-to-female incidence ratio was 1.93:1. Prevalence was 3.44 (95% CI 2.01-5.52) cases per 100,000 inhabitants on 31<sup>st</sup> December 2018. Whole-genome sequencing allowed us to determine rare DNA variants that change the protein-coding sequence of ALS-associated genes. Interestingly, the Maltese ALS patient cohort was found to be negative for deleterious variants in C9orf72, SOD1, TARDBP or FUS genes, which are the most commonly mutated ALS genes globally. Nonetheless, ALS-associated repeat expansions were identified in ATXN2 and NIPA1. Variants predicted to be damaging were also detected in ALS2, DAO, DCTN1, ERBB4, SETX, SCFD1 and SPG11. A total of 40% of patients with sporadic ALS had a rare and deleterious variant or repeat expansion in an ALS-associated gene, whilst the genetic cause of two thirds of fALS cases could not be pinpointed to known ALS genes or risk loci. This warrants further studies to elucidate novel genes that cause ALS in this unique population isolate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borg</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrugia Wismayer</LastName><ForeName>Maia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonavia</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrugia Wismayer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vella</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Vugt</LastName><ForeName>Joke J F A</ForeName><Initials>JJFA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenna</LastName><ForeName>Brendan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenna</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassallo</LastName><ForeName>Neville</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cauchi</LastName><ForeName>Ruben J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-6150-1608</Identifier><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, Biomedical Sciences Building, University of Malta, Msida, Malta. ruben.cauchi@um.edu.mt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta. ruben.cauchi@um.edu.mt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Hum Genet</MedlineTA><NlmUniqueID>9302235</NlmUniqueID><ISSNLinking>1018-4813</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="Y">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008319" MajorTopicYN="N" Type="Geographic">Malta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060047" MajorTopicYN="Y">Reproductive Isolation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33414559</ArticleId><ArticleId IdType="pmc">PMC8115635</ArticleId><ArticleId IdType="doi">10.1038/s41431-020-00767-9</ArticleId><ArticleId IdType="pii">10.1038/s41431-020-00767-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;72..</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;98..</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;30..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81:1324&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg BB, Garton FC, van Rheenen W, Fang F, Henderson RD, Mortensen PB, et al. ALS in Danish registries: heritability and links to psychiatric and cardiovascular disorders. Neurol Genet. 2020;6:e398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7073454</ArticleId><ArticleId IdType="pubmed">32211514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson SB, Downie JM, Tsetsou S, Feusier JE, Figueroa KP, Bromberg MB, et al. The evolving genetic risk for sporadic ALS. Neurology. 2017;89:226&#x2013;33..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet. 2013;50:776&#x2013;83..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812897</ArticleId><ArticleId IdType="pubmed">23881933</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;75..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009;41:1083&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly CV, Miller TM. Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis. Curr Opin Neurol. 2018;31:648&#x2013;54..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291817</ArticleId><ArticleId IdType="pubmed">30028737</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcos-Burgos M, Muenke M. Genetics of population isolates. Clin Genet. 2002;61:233&#x2013;47..</Citation><ArticleIdList><ArticleId IdType="pubmed">12030885</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruana J. Population genetics of Western Mediterranean Islands&#x2014;Malta: a case study. Manchester: University of Manchester; 2012.</Citation></Reference><Reference><Citation>Capelli C, Redhead N, Romano V, Cali F, Lefranc G, Delague V, et al. Population structure in the Mediterranean basin: a Y chromosome perspective. Ann Hum Genet. 2006;70:207&#x2013;25..</Citation><ArticleIdList><ArticleId IdType="pubmed">16626331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar M, Farrugia C, Vidal C. Allele frequencies of 14 STR loci in the population of Malta. Leg Med. 2008;10:153&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18039589</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg J, Papadopoulos P, Georgitsi M, Gutierrez L, Grech G, Fanis P, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet. 2010;42:801&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2930131</ArticleId><ArticleId IdType="pubmed">20676099</ArticleId></ArticleIdList></Reference><Reference><Citation>Said E, Chong JX, Hempel M, Denecke J, Soler P, Strom T, et al. Survival beyond the perinatal period expands the phenotypes caused by mutations in GLE1. Am J Med Genet A. 2017;173:3098&#x2013;103..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659324</ArticleId><ArticleId IdType="pubmed">28884921</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2000;1:293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolzhenko E, van Vugt J, Shaw RJ, Bekritsky MA, van Blitterswijk M, Narzisi G, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Res. 2017;27:1895&#x2013;903..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5668946</ArticleId><ArticleId IdType="pubmed">28887402</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelow D, Schuelke M. HomozygosityMapper2012-bridging the gap between homozygosity mapping and deep sequencing. Nucleic Acids Res. 2012;40:W516&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3394249</ArticleId><ArticleId IdType="pubmed">22669902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;83 e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, van Rheenen W, Pulit SL, Kenna KP, van den Berg LH, Veldink JH, et al. The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:432&#x2013;40..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015;24:2125&#x2013;37..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375422</ArticleId><ArticleId IdType="pubmed">25552646</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol. 2013;74:699&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">23836460</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, et al. Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis. JAMA Neurol. 2017;74:1425&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5822189</ArticleId><ArticleId IdType="pubmed">29049464</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Mariosa D, Larsson H, Ye W, Ingre C, Almqvist C, et al. Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis. Neurology. 2017;89:578&#x2013;85..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5562958</ArticleId><ArticleId IdType="pubmed">28701495</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, Visser AE, D&#x2019;Ovidio F, Vlaanderen J, Portengen L, Beghi E, et al. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. J Neurol Neurosurg Psychiatry. 2020;91:33&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31434759</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, Rooney JPK, D&#x2019;Ovidio F, Westeneng HJ, Vermeulen RCH, Beghi E, et al. Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89:797&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">29685899</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gaetano C, Voglino F, Guarrera S, Fiorito G, Rosa F, Di Blasio AM, et al. An overview of the genetic structure within the Italian population from genome-wide data. PLoS ONE. 2012;7:e43759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3440425</ArticleId><ArticleId IdType="pubmed">22984441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarno S, Boattini A, Pagani L, Sazzini M, De Fanti S, Quagliariello A, et al. Ancient and recent admixture layers in Sicily and Southern Italy trace multiple migration routes along the Mediterranean. Sci Rep. 2017;7:1984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434004</ArticleId><ArticleId IdType="pubmed">28512355</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;68..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, et al. The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet. 2013;21:102&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522204</ArticleId><ArticleId IdType="pubmed">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauw HM, van Rheenen W, Koppers M, Van Damme P, Waibel S, Lemmens R, et al. NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:2497&#x2013;502..</Citation><ArticleIdList><ArticleId IdType="pubmed">22378146</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology. 2011;76:2066&#x2013;72..</Citation><ArticleIdList><ArticleId IdType="pubmed">21562247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazelaar GHP, Dekker AM, van Vugt J, van der Spek RA, Westeneng HJ, Kool L, et al. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort. Neurobiol Aging. 2019;74:234 e9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893598</ArticleId><ArticleId IdType="pubmed">30342764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragonese P, Cellura E, Aridon P, D&#x2019;Amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13:284&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22409362</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1739746</ArticleId><ArticleId IdType="pubmed">16024886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, et al. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur J Neurol. 2006;13:789&#x2013;92..</Citation><ArticleIdList><ArticleId IdType="pubmed">16834713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacem I, Sghaier I, Bougatef S, Nasri A, Gargouri A, Ajroud-Driss S, et al. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31858811</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetriou CA, Hadjivasiliou PM, Kleopa KA, Christou YP, Leonidou E, Kyriakides T, et al. Epidemiology of amyotrophic lateral sclerosis in the Republic of Cyprus: A 25-year retrospective study. Neuroepidemiology. 2017;48:79&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">28528330</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385&#x2013;90..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradas J, Puig T, Rojas-Garcia R, Viguera ML, Gich I, Logroscino G, et al. Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:278&#x2013;83..</Citation><ArticleIdList><ArticleId IdType="pubmed">23286747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:262&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24863640</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo C, Novi G, Bandettini di Poggio M, Canosa A, Sormani MP, Mandich P, et al. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: an update of LIGALS register. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:535&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">27399231</ArticleId></ArticleIdList></Reference><Reference><Citation>Palese F, Sartori A, Verriello L, Ros S, Passadore P, Manganotti P, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:90&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30430867</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882 e7&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4252367</ArticleId><ArticleId IdType="pubmed">25123918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, Doherty MA, Davis N, Corr EM, Vajda A, et al. Determining the incidence of familiality in ALS: A study of temporal trends in Ireland from 1994 to 2016. Neurol Genet. 2018;4:e239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961194</ArticleId><ArticleId IdType="pubmed">29845113</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O&#x2019;Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8:14774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364411</ArticleId><ArticleId IdType="pubmed">28322246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166&#x2013;73..</Citation><ArticleIdList><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentati A, Bejaoui K, Pericak-Vance MA, Hentati F, Speer MC, Hung WY, et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet. 1994;7:425&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7920663</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A, et al. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging. 2012;33:839 e5&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154821</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:3776&#x2013;84..</Citation><ArticleIdList><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci USA. 2010;107:7556&#x2013;61..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867752</ArticleId><ArticleId IdType="pubmed">20368421</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet. 2013;93:900&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4) Am J Hum Genet. 2004;74:1128&#x2013;35..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K, Torok D, Goudenege D, Farkas K, Sulak A, Torok N, et al. High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain Behav. 2017;7:e00669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5390843</ArticleId><ArticleId IdType="pubmed">28413711</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquilina B, Cauchi RJ. Modelling motor neuron disease in fruit flies: lessons from spinal muscular atrophy. J Neurosci Methods. 2018;310:3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">29649521</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>